| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |